Multi‑institutional development and validation of a nomogram to predict prognosis of early-onset gastric cancer patients

Abstract

BackgroundEarly-onset gastric cancer (EOGC, ≤45 years old) is characterized with increasing incidence and more malignant phenotypes compared with late-onset gastric cancer, which exhibits remarkable immune cell infiltration and is potential immunotherapeutic population. Till now, restricted survival information of EOGC is available due to limited case numbers. This study established a novel nomogram to help evaluate cancer-specific survival (CSS) of EOGC patients who underwent gastrectomy, and may provide evidence for predicting patients’ survival.MethodsWe retrospectively enrolled a cohort containing 555 EOGC cases from five independent medical centers in China, among which 388 cases were randomly selected into a training set while the other 167 cases were assigned into the internal validation set. Asian or Pacific Islander (API) patients diagnosed with EOGC during 1975-2016 were retrieved from the SEER database (n=299) and utilized as the external validation cohort. Univariate and multivariate analyses were conducted to test prognostic significances of clinicopathological factors in the training set. Accordingly, two survival nomogram models were established and compared by concordance index (C-index), calibration curve, receiver operating characteristics (ROC) curves and decision curve analyses (DCA).ResultsThe 5-year CSS rate of training cohort was 61.3% with a median survival time as 97.2 months. High consistency was observed on calibration curves in all three cohorts. Preferred nomogram was selected due to its better performance on ROC and DCA results. Accordingly, a novel predicative risk model was introduced to better stratify high-risk EOGC patients with low-risk patients. In brief, the 5-year CSS rates for low-risk groups were 92.9% in training set, 83.1% in internal validation set, 89.9% in combined NQSQS cohort, and 85.3% in SEER-API cohort. In contrast, the 5-year CSS rates decreased to 38.5%, 44.3%, 40.5%, and 36.9% in the high-risk groups of the four cohorts above, respectively. The significant survival difference between high-risk group (HRG) and low-risk group (LRG) indicated the precise accuracy of our risk model. Furthermore, the risk model was validated in patients with different TNM stages, respectively. Finally, an EOGC web-based survival calculator was established with public access, which can help predict prognosis.ConclusionsOur data provided a precise nomogram on predicting CSS of EOGC patients with potential clinical applicability.

Systematically Prognostic Analyses of Gastric Cancer Patients with Ovarian Metastasis

“…This means that several prognostic factors (such as the tumor size) may lose their significant effect on the survival of those patients with very late stage. Liu et al's data described the entire younger gastric cancer patients and concluded that early-onset gastric cancer cases showed worse survival compared with late-onset gastric cancers [ 12 ], while our data only compared patients with ovarian metastasis. Therefore, the conclusions are completely different.…”

Survival nomogram and risk classification system for patients with adrenocortical carcinoma: a study based on the SEER database and external validation in China

“…Despite the diverse therapeutic approaches available, ACC remains to be characterized by high recurrence and mortality rates. In many malignancies, the application of nomograms has demonstrated superior accuracy compared to conventional staging systems ( 15 - 17 ). For instance, the TNM staging system fails to account for several crucial risk factors, such as age and treatment response.…”

Clinical Significance of NKD Inhibitor of WNT Signaling Pathway 1 (NKD1) in Glioblastoma

“…Survival analysis was performed using the univariate and multivariate Cox hazard regression method. SPSS 22.0 and GraphPad Prism 7.0 Software were used for data analyses [21]. P < 0.05 was defned as statistical signifcance.…”